[{"AccountsPayableCurrent_0_Q1_USD":3527000.0,"DebtSecuritiesAvailableForSaleGainLoss_1_Q1_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":13343000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":49776000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":170930000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":3524000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":2255000.0,"ConvertibleDebtFairValueDisclosures_0_Q1_USD":181500000.0,"AvailableForSaleSecuritiesNoncurrent_0_Q1_USD":16510000.0,"LongTermDebtFairValue_0_Q1_USD":45300000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":5229000.0,"OtherLiabilitiesCurrent_0_Q1_USD":2507000.0,"IncreaseDecreaseInContractWithCustomerAsset_1_Q1_USD":0.0,"IncreaseDecreaseInAccountsPayableTrade_1_Q1_USD":-4633000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":408000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":934000.0,"OperatingLeaseExpense_1_Q1_USD":1400000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-38471000.0,"EquitySecuritiesFvNi_0_Q1_USD":600000.0,"EquitySecuritiesFvNiUnrealizedGainLoss_1_Q1_USD":-400000.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q1_USD":0.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q1_USD":0.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_1_Q1_USD":55122000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_1_Q1_USD":10592000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q1_USD":934000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.09,"OperatingLeasePayments_1_Q1_USD":2000000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":1774000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":5030000.0,"OperatingLeaseLiability_0_Q1_USD":6804000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":857038000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":552000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":4616000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":12694000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":16195000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q1_USD":16648000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q1_USD":170919000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":225023000.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_1_Q1_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_1_Q1_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":3951000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":3825000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":2002000.0,"NonoperatingIncomeExpense_1_Q1_USD":723000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-30135000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":43489000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-11000.0,"LiabilitiesCurrent_0_Q1_USD":20741000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":256582000.0,"Liabilities_0_Q1_USD":302293000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-949000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-2459000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":12449000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.66,"CommonStockValue_0_Q1_USD":59000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":49776000.0,"AssetsCurrent_0_Q1_USD":225938000.0,"Assets_0_Q1_USD":256582000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":27148000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":1613000.0,"AccountsReceivableNetCurrent_0_Q1_USD":2704000.0,"NetIncomeLoss_1_Q1_USD":-39405000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":1041000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":2528000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":0.0,"LongTermDebtNoncurrent_0_Q1_USD":45340000.0,"AdjustmentsToAdditionalPaidInCapitalWarrantIssued_1_Q1_USD":184000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":93000.0,"ShareBasedCompensation_1_Q1_USD":3524000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":21738000.0,"PreferredStockValue_0_Q1_USD":0.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"OperatingIncomeLoss_1_Q1_USD":-30362000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-1064000.0,"OperatingExpenses_1_Q1_USD":34187000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"CommitmentsAndContingencies_0_Q1_USD":0.0,"AccruedLiabilitiesCurrent_0_Q1_USD":9677000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":59270.0,"StockholdersEquity_0_Q1_USD":-45711000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-904421000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":5162000.0,"ProfitLoss_1_Q1_USD":-39405000.0,"InterestExpense_1_Q1_USD":4077000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":1106000.0,"Ticker":"CYTK","CIK":"1061983","name":"CYTOKINETICS INC","OfficialName":"Cytokinetics Incorporated Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"3243164482.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200508"}]